Incyte Corp (INCY)
53.06
-0.44
(-0.82%)
USD |
NASDAQ |
May 10, 16:00
53.06
0.00 (0.00%)
After-Hours: 20:00
Incyte Price: 53.06 for May 10, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 10, 2024 | 53.39 | 53.67 | 52.81 | 53.06 | 1.505M |
May 09, 2024 | 53.76 | 53.94 | 53.10 | 53.50 | 1.428M |
May 08, 2024 | 54.37 | 54.49 | 53.23 | 53.51 | 2.209M |
May 07, 2024 | 54.50 | 54.92 | 53.96 | 54.37 | 1.901M |
May 06, 2024 | 53.79 | 54.19 | 53.45 | 54.08 | 2.017M |
May 03, 2024 | 53.70 | 53.87 | 52.73 | 53.76 | 1.407M |
May 02, 2024 | 53.02 | 53.46 | 52.28 | 53.09 | 2.021M |
May 01, 2024 | 51.87 | 53.98 | 51.75 | 52.94 | 3.578M |
Apr 30, 2024 | 50.40 | 53.84 | 50.35 | 52.05 | 4.773M |
Apr 29, 2024 | 51.75 | 53.27 | 51.71 | 52.56 | 3.082M |
Apr 26, 2024 | 50.99 | 51.85 | 50.87 | 51.68 | 1.564M |
Apr 25, 2024 | 51.58 | 51.85 | 50.35 | 51.18 | 1.772M |
Apr 24, 2024 | 51.65 | 51.84 | 51.14 | 51.74 | 1.564M |
Apr 23, 2024 | 52.00 | 52.22 | 51.39 | 51.65 | 2.494M |
Apr 22, 2024 | 52.43 | 52.62 | 51.88 | 51.92 | 1.752M |
Apr 19, 2024 | 52.97 | 53.00 | 52.00 | 52.35 | 2.181M |
Apr 18, 2024 | 52.96 | 53.15 | 52.26 | 52.82 | 1.830M |
Apr 17, 2024 | 53.22 | 53.80 | 52.70 | 52.72 | 2.526M |
Apr 16, 2024 | 53.34 | 54.09 | 53.15 | 53.22 | 1.465M |
Apr 15, 2024 | 53.91 | 54.30 | 53.41 | 53.43 | 1.574M |
Apr 12, 2024 | 54.72 | 55.03 | 53.76 | 53.85 | 1.227M |
Apr 11, 2024 | 55.34 | 55.99 | 54.63 | 54.92 | 1.581M |
Apr 10, 2024 | 54.85 | 55.25 | 54.47 | 55.00 | 1.053M |
Apr 09, 2024 | 55.20 | 56.46 | 55.19 | 55.30 | 1.483M |
Apr 08, 2024 | 54.97 | 55.42 | 54.42 | 55.05 | 1.239M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
51.18
Minimum
Apr 25 2024
109.69
Maximum
Jul 20 2020
76.29
Average
76.92
Median
Aug 05 2021
Price Benchmarks
Biogen Inc | 221.50 |
Illumina Inc | 110.53 |
Pfizer Inc | 28.01 |
Bristol-Myers Squibb Co | 44.94 |
Eli Lilly and Co | 760.00 |
Price Related Metrics
PE Ratio | 16.08 |
PS Ratio | 3.188 |
PEG Ratio | 0.126 |
Price to Book Value | 2.209 |
Price to Free Cash Flow | 15.19 |
Earnings Yield | 6.22% |
Market Cap | 11.91B |
PEGY Ratio | 0.126 |
Operating PE Ratio | 16.92 |
Normalized PE Ratio | 18.32 |